Cliffs Honored for $250,000 Gift


Northern Michigan University’s clinical laboratory sciences programs have received a $250,000 commitment, disbursed over five years, from the Cliffs Natural Resources Foundation. This is Cliffs’ largest gift to NMU. It will support the molecular diagnostics initiative.

Pictured at the presentation of an NMU flag honoring the Cliffs gift are (from left): Kerri Schuiling, dean of Health Sciences and Professional Studies; Linda Riipi, associate dean and director of the School of Clinical Sciences; Dale Hemmila, Cliffs director of public affairs, North America; NMU President Fritz Erickson; and Dave Bammert, NMU Foundation development officer. For more on the molecular diagnostics initiative and how the Cliffs funding will be used, read this story from a previous issue of CAMPUS.

News and Information



19th Annual Celebration of Student Research, Creative Works and Academic Service Learning

Kelsey Mitchell, Senior, Clinical Sciences - Science Technology, submitted a poster on Method Validation in the Clinical Laboratory. Method validation is performed in the clinical laboratory each time a new methodology or instrumentation is put into place.  The goal of a validation study is to determine the degree of error that established by the Clinical Laboratory Improvement Act (CLIA '88) Final Rule which require that laboratories verify, among several items, the precision and accuracy of laboratory methods implemented after April 24, 2003. 

Tony Treloar, Junior, CLS Microbiology concentration, submitted a poster on Laser-Based Rapid Identification of Bacterial Pathogens along with Kaylagh Hollen, Senior, Biology.  The Sharp laboratory at NMU will be collaborating with Micro Identification Technologies (MIT) to expand their technology to identify and differentiate Staphylococcus aureus, and methicillin resistant Staphylococcus aureus (MRSA).  The goals are to determine the light scattering patterns for S aureus and MRSA, and then utilize that data to identify these pathogens in clinical samples. 



Patricia Rempala, Sophomore, Clinical Sciences-Clinical Laboratory Science, submitted a poster on Designing an Intraoperative Assay to Detect the IDH-1 Mutation and MGMT Methylation in Glioblastoma.  The purpose of this study was to develop a rapid intraoperative PCR assay (<25 minutes) to detect the IDH-1 mutation and the MGMT methylation status in glioblastomas.  This genetic information will allow the neurosurgeon to determine an individualized treatment plan for the patient during surgery.


New Master of Science in Clinical Molecular Genetics Program

The program features online coursework with an on-campus laboratory experience. Students choose from two tracks: professional, project-based for working professionals or research, thesis-based in preparation for positions in industry, including pharmaceuticals, biotechnology, government and academe. Learn more here

School of Clinical Sciences
Upcoming Deadlines

and Policy Manual

All applications are located in the School of Clinical Sciences Policy Manual, which can be purchased in the Bookstore.  Click here to view the Policy Manual.

Right Brown Box

Academic Program Videos
Student talks about Respiration Therapy

Students talk about their experiences and opportunities within the majors of the School of Clinical Sciences.

Anatomical Pathology  

Clinical Laboratory Science 

Diagnostic Genetics 

Laboratory Medicine  



Speech, Language, and Hearing Sciences

Surgical Technology

School of Clinical Sciences